Lifeward Ltd. reported a 12% revenue decline to $5.4 million in Q3 2026, driven by a strategic shift of its ReWalk exoskeleton sales from direct to channel-partner distribution, which temporarily reduced sales. Meanwhile, AlterG revenue rose 18% to $3.6 million due to increased U.S. shipments and higher prices. The company is expanding ReWalk's patient access through partnerships and Medicare coverage, supported by new clinical evidence and AI-enabled rehabilitation tech development. Despite higher operating losses and expenses, Lifeward aims for long-term growth by leveraging its diversified biomedical portfolio and evolving distribution model.
Lifeward's third quarter 2026 financial results provide context for the health sector's performance on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 20:42 WIB: out of 150 priced US health-sector stocks, 107 rose and 39 fell today. Notable movers include AHCO at USD 7.68 with a 1-day change of -2.41% and 100% sell order activity, ABCL at USD 11.87 up 2.15% with 79% buy orders, and COO at USD 63.52 up 2.14%, with a typical hold time of 12 days on Pluang.
On November 12, 2026, Nokia executive Pallavi Mahajan acquired 89 shares of Nokia Corporation at a price of €7.63 per share. This insider purchase is officially reported under EU Market Abuse Regulation Article 19. Such transactions by company execut...
David Heard, a senior manager at Nokia Corporation, purchased 1,139 shares of the company on November 12, 2026, at a price of €7.63 per share. This transaction was reported under EU Market Abuse Regulation, signaling insider confidence or strategic i...
Victoria Hanrahan, a senior executive at Nokia Corporation, purchased 6 shares of Nokia stock at a price of €7.63 per share on November 12, 2026. This transaction was reported under EU Market Abuse Regulation Article 19, indicating transparency in in...
Louise A. Fisk, a senior executive at Nokia Corporation, acquired 235 shares of Nokia stock at a price of €7.63 per share on November 12, 2026. This transaction was reported under the EU Market Abuse Regulation, signaling insider activity. Such purch...
Nokia executive David A. Heard purchased 1,139 shares of Nokia stock at a price of €7.63 per share on November 12, 2026. This transaction was reported under EU Market Abuse Regulation Article 19, indicating compliance with market transparency rules. ...
